FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
TransMedics Group, Inc. Stock AnalysisComprehensive stock analysis for TransMedics Group, Inc. (TMDX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisTMDX
TMDX
TransMedics Group, Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
TMDX
Home🔹Stocks🔹TransMedics Group, Inc.

TransMedics Group, Inc.

TMDX•NASDAQ

TransMedics Group, Inc.

TMDX•NASDAQ
Market cap
$2.64B
Sentiment

Your view on TMDX

Mkt Cap
$2.64B
Sentiment
Your view
TMDX
TransMedics Group, Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
TMDX
Company Overview

Overview

What the company does, where it operates, and who runs it.

About TransMedics Group, Inc.

Industry
Medical - Devices
Sector
Healthcare
CEO
Waleed H. Hassanein
Headquarters
200 Minuteman Road, Andover, MA, US
Industry
Medical - Devices
Sector
Healthcare
CEO
Waleed H. Hassanein
Headquarters
200 Minuteman Road, Andover, MA, US
Description

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News